Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Other 1

Conditions

Obesity 9Endometrial Neoplasms 5Prostatic Neoplasms 2Overweight 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Opioid-Related Disorders 1Metabolic Syndrome 1Lymphoma, Follicular 1Insulin Resistance 1Inflammation 1Hyperplasia 1Endometrial Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Tirzepatide × Clear all
NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Weill Medical College of Cornell University

Phase 4 Not yet recruiting
30 enrolled
BreastOther

Breast Neoplasms, Obesity

NCT06517212 2026-02-12

TRIM-EBC

Baylor Research Institute

Phase 2 Recruiting
48 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡